10-Q Filing

NEOGENOMICS INC CIK: 1077183 Q1 2016

Filing Information

Form Type	10-Q
Accession Number	`0001564590-16-018998`
Period End Date	20160331
Filing Date	20160510
Fiscal Year	2016
Fiscal Period	Q1
XBRL Instance	neo-20160331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 40 Cash Flow Statement 49

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$4.76M	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$7.34M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$30.14M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$26.53M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$33.69M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$31.25M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$23.42M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.26M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Accounts receivable (net of allowance for doubtful accounts of $7,343 and $4,759, respectively)	`AccountsReceivableNetCurrent`	$50.09M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Accounts receivable (net of allowance for doubtful accounts of $7,343 and $4,759, respectively)	`AccountsReceivableNetCurrent`	$48.94M	USD	Point-in-time
Inventories	`InventoryNet`	$5.33M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	77.03M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	75.82M	shares	Point-in-time
Inventories	`InventoryNet`	$5.11M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	77.03M	shares	Point-in-time
Other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.53M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	75.82M	shares	Point-in-time
Other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.89M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$82.36M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$81.20M	USD	Point-in-time
Property and equipment (net of accumulated depreciation of $30,135 and $26,534, respectively)	`PropertyPlantAndEquipmentNet`	$33.56M	USD	Point-in-time
Property and equipment (net of accumulated depreciation of $30,135 and $26,534, respectively)	`PropertyPlantAndEquipmentNet`	$34.58M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$87.80M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$85.77M	USD	Point-in-time
Goodwill	`Goodwill`	$146.18M	USD	Point-in-time
Goodwill	`Goodwill`	$146.42M	USD	Point-in-time
Goodwill	`Goodwill`	$2.93M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$129.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$129.00K	USD	Point-in-time
Total assets	`Assets`	$351.29M	USD	Point-in-time
Total assets	`Assets`	$346.84M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$12.46M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$15.29M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$9.19M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$6.22M	USD	Point-in-time
Accrued expenses and other liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$4.98M	USD	Point-in-time
Accrued expenses and other liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$7.37M	USD	Point-in-time
Revolving credit facility, net	`LineOfCredit`	$8.87M	USD	Point-in-time
Short-term portion of capital leases	`CapitalLeaseObligationsCurrent`	$4.27M	USD	Point-in-time
Short-term portion of capital leases	`CapitalLeaseObligationsCurrent`	$4.53M	USD	Point-in-time
Short-term portion of loans	`LongTermDebtCurrent`	$600.00K	USD	Point-in-time
Short-term portion of loans	`LongTermDebtCurrent`	$596.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$34.32M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$40.06M	USD	Point-in-time
Long-term portion of capital leases	`CapitalLeaseObligationsNoncurrent`	$4.12M	USD	Point-in-time
Long-term portion of capital leases	`CapitalLeaseObligationsNoncurrent`	$5.04M	USD	Point-in-time
Long-term portion of loans, net	`LongTermDebtNoncurrent`	$52.34M	USD	Point-in-time
Long-term portion of loans, net	`LongTermDebtNoncurrent`	$52.32M	USD	Point-in-time
Deferred income tax liability, net	`DeferredTaxLiabilitiesNoncurrent`	$15.74M	USD	Point-in-time
Deferred income tax liability, net	`DeferredTaxLiabilitiesNoncurrent`	$15.92M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$73.12M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$72.36M	USD	Point-in-time
Total liabilities	`Liabilities`	$113.17M	USD	Point-in-time
Total liabilities	`Liabilities`	$106.67M	USD	Point-in-time
Commitments and contingencies - see Note I	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies - see Note I	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $.001 par value, (250,000,000 shares authorized; 77,033,608 and 75,820,307 shares issued and outstanding, respectively)	`CommonStockValueOutstanding`	$76.00K	USD	Point-in-time
Common stock, $.001 par value, (250,000,000 shares authorized; 77,033,608 and 75,820,307 shares issued and outstanding, respectively)	`CommonStockValueOutstanding`	$77.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$233.40M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$231.38M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-27.48M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-21.94M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$209.51M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$206.00M	USD	Point-in-time
Total liabilities, redeemable convertible preferred stock and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$351.29M	USD	Point-in-time
Total liabilities, redeemable convertible preferred stock and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$346.84M	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Clinical testing revenue	`ClinicalTestingRevenue`	$54.62M	USD	1 Quarter
Clinical testing revenue	`ClinicalTestingRevenue`	$22.84M	USD	1 Quarter
BioPharma & research revenue	`BioPharmaAndResearchRevenue`	$187.00K	USD	1 Quarter
BioPharma & research revenue	`BioPharmaAndResearchRevenue`	$5.08M	USD	1 Quarter
Total Revenue, net	`SalesRevenueServicesNet`	$59.70M	USD	1 Quarter
Total Revenue, net	`SalesRevenueServicesNet`	$23.03M	USD	1 Quarter
COST OF REVENUE	`CostOfServices`	$32.53M	USD	1 Quarter
COST OF REVENUE	`CostOfServices`	$13.48M	USD	1 Quarter
GROSS MARGIN	`GrossProfit`	$9.54M	USD	1 Quarter
GROSS MARGIN	`GrossProfit`	$27.17M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$18.00M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$6.52M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$669.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.45M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$2.91M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$5.80M	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$10.11M	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$25.25M	USD	1 Quarter
INCOME (LOSS) FROM OPERATIONS	`OperatingIncomeLoss`	$1.92M	USD	1 Quarter
INCOME (LOSS) FROM OPERATIONS	`OperatingIncomeLoss`	$-561.00K	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$1.59M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$195.00K	USD	1 Quarter
Income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$329.00K	USD	1 Quarter
Income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-756.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$174.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$5.00K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-761.00K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$155.00K	USD	1 Quarter
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$1.84M	USD	1 Quarter
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$3.73M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-761.00K	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.41M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.07	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.07	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	76.07M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	60.28M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	76.07M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	60.28M	shares	1 Quarter

Cash Flow Statement 49 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-761.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$155.00K	USD	1 Quarter
Depreciation	`Depreciation`	$3.58M	USD	1 Quarter
Depreciation	`Depreciation`	$1.59M	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$2.03M	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$93.00K	USD	1 Quarter
Amortization of debt issue costs	`AmortizationOfFinancingCosts`	$182.00K	USD	1 Quarter
Stock based compensation options, restricted stock and warrants	`ShareBasedCompensationAndWarrants`	$401.00K	USD	1 Quarter
Stock based compensation options, restricted stock and warrants	`ShareBasedCompensationAndWarrants`	$703.00K	USD	1 Quarter
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$602.00K	USD	1 Quarter
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$2.66M	USD	1 Quarter
(Increase) in accounts receivable, net of write-offs	`IncreaseDecreaseInAccountsReceivable`	$3.81M	USD	1 Quarter
(Increase) in accounts receivable, net of write-offs	`IncreaseDecreaseInAccountsReceivable`	$1.61M	USD	1 Quarter
(Increase) decrease in inventories	`IncreaseDecreaseInInventories`	$225.00K	USD	1 Quarter
(Increase) decrease in inventories	`IncreaseDecreaseInInventories`	$-21.00K	USD	1 Quarter
Decrease (increase) in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$401.00K	USD	1 Quarter
Decrease (increase) in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$42.00K	USD	1 Quarter
Decrease in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-1.00K	USD	1 Quarter
(Decrease) in accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$2.18M	USD	1 Quarter
(Decrease) in accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$-1.08M	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$7.06M	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-787.00K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.00M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$842.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-1.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-842.00K	USD	1 Quarter
Repayment of revolving credit facility	`RepaymentsOfLinesOfCredit`	$10.04M	USD	1 Quarter
Repayment of capital lease obligations/loans	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$921.00K	USD	1 Quarter
Repayment of capital lease obligations/loans	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$1.38M	USD	1 Quarter
Issuance of common stock for the exercise of options, warrants and ESPP shares, net of transaction expenses	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$1.20M	USD	1 Quarter
Issuance of common stock for the exercise of options, warrants and ESPP shares, net of transaction expenses	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$109.00K	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-812.00K	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-10.22M	USD	1 Quarter
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-4.16M	USD	1 Quarter
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.44M	USD	1 Quarter
Cash and cash equivalent, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$33.69M	USD	Point-in-time
Cash and cash equivalent, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$31.25M	USD	Point-in-time
Cash and cash equivalent, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$23.42M	USD	Point-in-time
Cash and cash equivalent, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$19.26M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$33.69M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$31.25M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$23.42M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$19.26M	USD	Point-in-time
Interest paid	`InterestPaid`	$212.00K	USD	1 Quarter
Interest paid	`InterestPaid`	$1.42M	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaid`	$207.00K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaid`	$5.00K	USD	1 Quarter
Equipment acquired under capital lease/loan obligations	`CapitalLeaseObligationsIncurred`	$173.00K	USD	1 Quarter
Equipment acquired under capital lease/loan obligations	`CapitalLeaseObligationsIncurred`	$2.52M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.